LUFYLLIN Drug Patent Profile
✉ Email this page to a colleague
When do Lufyllin patents expire, and what generic alternatives are available?
Lufyllin is a drug marketed by Mylan Speciality Lp and is included in one NDA.
The generic ingredient in LUFYLLIN is dyphylline. There are two drug master file entries for this compound. Additional details are available on the dyphylline profile page.
Summary for LUFYLLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Patent Applications: | 3,544 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LUFYLLIN at DailyMed |
US Patents and Regulatory Information for LUFYLLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Speciality Lp | LUFYLLIN | dyphylline | TABLET;ORAL | 084566-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan Speciality Lp | LUFYLLIN | dyphylline | TABLET;ORAL | 084566-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |